Healthtech and Medtech Go-to-Market Strategy in India: A Founder’s Guide (2026)

The short answer: A healthtech go-to-market strategy (and a medtech GTM strategy) for India means understanding who really buys inside hospitals, positioning your product around hospital economics and clinical value, earning the trust of a few respected doctors, designing pilots that convert into purchases, choosing the right partners, and getting in front of the right healthcare leaders. Products rarely fail in India for lack of technology. They stall because the right people did not know, trust or buy them.

This guide is for founders, product leaders and country heads of healthtech, medtech, digital health and pharma-tech companies, both Indian startups and overseas firms planning to enter India. It is written by Akhil Dave, who has spent 25+ years in healthcare marketing strategy and leads HMS Consultants, a healthcare marketing and strategy consultancy that helps healthtech and medtech companies build their India go-to-market using deep market experience and a wide network of healthcare providers.

Why India is worth the effort, and why it is hard

The opportunity is large and still import-led. The Indian medical devices market was estimated at about $15.2 billion in 2025, projected to reach $50.1 billion by 2030, with imports covering roughly 70 to 80 per cent of domestic demand, according to a Rubix Industry Insights report cited by IANS. On the digital side, the Ayushman Bharat Digital Mission had crossed 93.95 crore ABHA IDs by July 2026, with 5.33 lakh health facilities and 9.85 lakh healthcare professionals registered. Funding is more selective: Inc42 reports roughly $700 million across 54 healthtech deals in 2025, against 78 deals in 2024. Capital now rewards companies with traction, not decks.

India is hard for three reasons. Buying is fragmented across thousands of hospitals, clinics and diagnostic chains. Trust travels through doctors and peers, not advertising. And every hospital decides differently. Treat each as a gate you must pass.

The 6-gate India GTM framework

We use six gates with healthtech and medtech teams. Skipping one usually shows up later as a stalled pilot or a sales team starting from zero in every new hospital.

Gate 1: Map who really buys inside a hospital

Most founders pitch the person who loves the product, then discover someone else holds the budget. Map the buying centre before you build a sales deck.

Gate 2: Position around hospital economics and clinical value

Hospital leaders buy outcomes, savings and differentiation. Doctors buy better care and an easier workflow. Your positioning should answer both in plain language: what problem you solve, for which department, with what measurable result, and why now. A good test: can a hospital COO repeat your value in one sentence after a ten-minute meeting? If not, the message needs work before any outreach starts.

Gate 3: Build clinical credibility through champions

In Indian healthcare, a respected clinician’s opinion carries more weight than any brochure. Start with three to five champion doctors across two or three cities, not fifty doctors who barely use the product.

• Pick opinion leaders, not just early adopters. One respected department head opens more doors than ten enthusiastic juniors.
• Use a trusted introduction. A warm introduction through someone the doctor already trusts shortens months of cold outreach. This is where an established provider network matters most.
• Remember doctors cannot advertise for you. Under NMC rules, doctors cannot endorse products using their name, image or professional status. Build credibility through scientific presentations, case studies, conferences and peer education instead, and confirm what is permitted with your legal advisor.

Gate 4: Design pilots that convert

A pilot without an agreed next step is a favour, not a sale. Before the pilot starts, agree in writing on four things: the clinical or operational question, the measurable outcome, the start and end dates, and what a successful pilot converts into, whether that is a purchase order, a rate contract or a multi-site rollout. Measure what the hospital cares about: turnaround time, error reduction, bed or OT utilisation, revenue per procedure and patient experience.

Gate 5: Choose direct, distributor or platform partners

Each route trades control for reach. A direct team gives you feedback and pricing control but needs capital and time. Distributors give reach and servicing but dilute your story. Hospital groups, diagnostic chains and healthtech platforms can give scale in one deal, at the price of dependence on one partner. Most companies start direct in one or two anchor cities, prove the playbook, then add partners region by region. Write your pricing, margin, training and after-sales commitments into the partner agreement before launch.

Gate 6: Build visibility and proof among the right healthcare leaders

Buyers, investors, partners and journalists research you before they take your call. Visibility in healthcare is about being known and trusted by the right few hundred people: hospital leaders, department heads, clinical opinion leaders, associations and conference organisers. Build it with a clear India story, founder and expert thought leadership, an active LinkedIn presence, third-party proof from pilots and conferences, and relationships that let others speak for you.

Keep healthcare communication responsible. Claims about outcomes must be verifiable, patient data needs proper consent, and healthcare advertising is regulated. Our guide to the NMC advertising guidelines explains how the rules affect doctors and hospitals you may work with.

What HMS Consultants does, and what it does not

HMS Consultants is a healthcare marketing and strategy consultancy. We build your go-to-market strategy, positioning, buyer and champion mapping, pilot design, partner approach and visibility plan, using our experience of the Indian healthcare market and our network of healthcare providers. We do not handle regulatory approvals, licensing, legal or clinical-compliance work. Those belong with your regulatory consultants and lawyers, and we plan your go-to-market timeline around them.

How our provider network shortens your India learning curve

A consultant who has worked on the hospital side sees what a foreign playbook misses: which departments really decide, how a purchase committee behaves, when to approach a hospital group, and which conference moves a doctor community. The HMS Consultants network connects founders with experienced healthcare marketing and strategy professionals and with hospitals, clinics and doctors across India, so a company can test, localise and scale its message with people who know each market.

Over recent months HMS has worked with healthtech companies including Expert AI and DocX System to build their visibility among doctors, hospital leaders and healthcare founders, and to connect them with the HMS network for strategic growth in India. That is the model: positioning first, visibility next, introductions third, and growth that follows trust.

Seven mistakes that slow healthtech and medtech GTM in India

1. Treating India as one market. Metro corporate hospitals, tier-2 private hospitals, single-doctor clinics and government hospitals buy differently.
2. Selling features, not hospital economics. Leaders buy outcomes, savings and differentiation.
3. Running free pilots with no conversion plan.
4. Depending on one champion doctor. People move; build relationships across departments.
5. Going to market before the message is clear. Outreach with a vague story burns your best contacts.
6. Ignoring the regulatory timeline. Launch plans must follow what your regulatory advisors confirm, not the other way around.
7. Using healthcare advertising tactics that work elsewhere. Doctor testimonials and influencer campaigns can backfire in India.

A 90-day India GTM plan

Frequently asked questions

What is a healthtech go-to-market strategy for India?

It is a plan that covers your buyers inside hospitals, your positioning, clinical champions, pilot design, sales channels and visibility, so a healthtech or medtech product can be adopted and paid for in India.

How do I enter the Indian healthcare market as a foreign medtech company?

Work on two tracks in parallel. Appoint regulatory and legal advisors to confirm what you need to sell legally in India, and build your go-to-market with a strategy partner: buyer map, positioning, champion doctors, pilots and channel partners.

Do you help with CDSCO registration or other approvals?

No. HMS Consultants is a healthcare marketing and strategy consultancy, not a regulatory or legal firm. We work alongside your regulatory advisors and plan your go-to-market around their timelines.

Who buys healthtech and medtech products inside Indian hospitals?

Several people share the decision: the treating doctor or HOD, hospital leadership, purchase and finance, IT, and biomedical engineering. Government hospitals add tender and procurement processes. Map all of them before pitching.

How can a healthtech startup get in front of hospitals and doctors in India?

Through trusted introductions, a few champion clinicians, credible proof from pilots, conference and association presence, and consistent thought leadership. A provider network shortens this considerably.

Can doctors endorse my healthtech or medtech product?

Under the NMC’s ethical advertising guidelines, doctors cannot endorse drugs, devices or health products using their name, image or professional status. Use scientific publications, educational events and compliant case studies, and confirm specifics with your legal advisor.

How long does it take to get the first hospital customers in India?

It varies by product, price point and hospital type. A structured 90-day plan can reach first pilots, but purchase decisions in larger hospitals often take longer. Plan the pilot and its conversion path from day one.

How can HMS Consultants help my healthtech or medtech GTM?

HMS Consultants, led by Akhil Dave, builds India go-to-market strategy for healthtech and medtech founders using its market expertise and network of healthcare providers and healthcare marketing consultants. See our healthcare startup strategy consulting.

Plan your India go-to-market with HMS Consultants

If you are a healthtech, medtech, digital health or pharma-tech founder planning to enter or scale in India, book a free 30-minute GTM discovery call. We will review your product and buyers, and tell you honestly where to focus first. Write to akhil@hmsconsultants.in or call +91 81550 04010.

Disclaimer: HMS Consultants is a healthcare marketing and strategy consultancy. We are not a law firm, a regulatory consultant or a clinical authority. This article reflects our understanding based on research of public sources and our experience, and is for general information only. Rules change, so confirm regulatory, legal and advertising points with qualified professionals before acting.

About the author: Akhil Dave is Founder and Principal Consultant of HMS Consultants, with 25+ years in healthcare marketing strategy.

Sources

• IANS: India’s medical devices market likely to hit $50.1 bn by 2030 (Rubix Industry Insights)
• Indian Pharma Post: Ayushman Bharat Digital Mission crosses 93.95 crore ABHA IDs
• Inc42: Top 30 funded healthtech startups in Bengaluru (2026)